Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran

European Journal of Neurology

Volumn 17, Issue 7, 2010, Pages 984-989

  Sajjadi, M ^a   Etemadifar, M ^b   Nemati, A ^a   Ghazavi, H ^a   Basiri, K ^b   Khoundabi, B ^b   Mousavi, S A ^b   Kabiri, P ^b,c   Maghzi, A H ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

amyotrophic lateral sclerosis; epidemiology; incidence; Iran; Isfahan; prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; YOUNG ADULT;

EID: 77953838740     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.02972.x     Document Type: Article

References (36)

1. Okamoto K, Kobashi G, Washio M, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol 2005 15: 20 23.
2. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003 60: 683 689.
3. Maragakis NJ, Galvez-Jimenez N. Epidemiology and Pathogenesis of Amyotrophic Lateral Sclerosis. http://www.UpToDateInc.com. (accessed 16/04/2007)
4. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007 68: 1002 1007.
5. Zadivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009 72: 1640 1645.
6. Vazquez MC, Ketzoian C, Legnani C, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 2008 30: 105 111.
7. Govoni V, Granieri E, Capone J, Manconi M, Casetta I. Incidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964-1998. Neuroepidemiology 2003 22: 229 234.
8. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994 124 (Suppl 96 107.
9. United States-QT-P1. Age Groups and Sex: 2000. United States Census Bureau. http://www.census.gov. (Accessed 09/08/2009)
10. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology 2007 68: 141 145.
11. Olivares L, Esteban ES, Alter M. Mexican "resistance" to amyotrophic lateral sclerosis. Arch Neurol 1972 27: 397 402.
12. Fong KY, Yu YL, Chan YW, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996 15: 239 245.
13. Bracco L, Antuono P, Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand 1979 60: 112 124.
14. Leone M, Chio A, Mortara P, Rosso MG, Schiffer D. Motor neuron disease in the Province of Turin, Italy, 1971-1980. Acta Neurol Scand 1983 68: 316 327.
15. Rosati G, Pinna L, Granieri E, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977 55: 231 244.
16. Moriwaka F, Okumura H, Tashiro K, et al. Motor neuron disease and past poliomyelitis. Geographic study in Hokkaido, the northern-most island of Japan. ALS Study Group. J Neurol 1993 240: 13 16.
17. Logroscino G, Beghi E, Zoccolella S, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005 76: 1094 1098.
18. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999 52: 504 509.
19. McGuire V, Longstreth WT Jr., Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996 47: 571 573.
20. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986 5: 61 70.
21. The Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992 55: 536 541.
22. Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008 79: 6 11.
23. Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2009 in press.
24. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008 79: 30 32.
25. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991 48: 589 593.
26. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009 72: 725 731.
27. Zoccolella S, Beghi E, Palagano G, et al. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol 2006 13: 789 792. (Pubitemid 44139382)
28. Li TM, Alberman E, Swash M. Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1990 53: 1043 1045.
29. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol 2007 254: 866 869.
30. Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004 33: 131 134.
31. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005 25: 114 119.
32. del Aguila MA, Longstreth WT Jr., McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003 60: 813 819.
33. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995 132: 207 215.
34. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983 67: 41 47.
35. Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993 240: 339 346. (Pubitemid 23230381)
36. Chio A, Mora G, Leone M, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002 59: 99 103. (Pubitemid 34742801)